Clinical Trial Details
— Status: Active, not recruiting
Administrative data
NCT number |
NCT03752684 |
Other study ID # |
IRB-131212001 |
Secondary ID |
|
Status |
Active, not recruiting |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
April 2, 2018 |
Est. completion date |
December 31, 2024 |
Study information
Verified date |
December 2023 |
Source |
University of Alabama at Birmingham |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
The purpose of this research study is to assess the efficacy of ingesting a small amount of
the harmless bacterium Oxalobacter formigenes in establishing residence in the guts of human
subjects and to determine whether this influences the oxalate passed in urine of healthy
volunteers.
Description:
Adults that are not colonized with O. formigenes, have no history of stone disease and are in
good health as judged by their medical history, a complete metabolic profile of their serum,
and ranges of ions that influence stone formation in two 24-hour urine collections, will be
recruited from within the greater Birmingham area. Recruited subjects will be between the
ages of 18 to 65 years and with a BMI >19 and <32.
Subjects not colonized with O. formigenes will consume, firstly, a controlled diet containing
50 mg oxalate and 1000mg calcium (low oxalate/normal calcium diet), followed by a 250 mg
oxalate/400mg calcium controlled diet (moderately high oxalate/low calcium diet), with at
least a one week washout between each diet, and then repeat the same sequence of diets after
colonization with O.formigenes Group 1 strain OxCC13. Controlled diets will be prepared in
the Metabolic Kitchen of the UAB Clinical Research Unit (CRU). Sustainability of colonization
will be determined over time. Loss of colonization will be confirmed by having the subject
consume an oxalate-rich meal with subsequent testing for O. formigenes.